Bicara Therapeutics Inc. Common Stock
$24.16
The Read: 2%, with past catalysts like strong Phase 3 trial initiations and positive ASCO data driving up to 8.
Price
Overlays
Panel
BCAX
Hover to view data
No Data
By creating an account you agree to our Terms of Service and Privacy Policy.
$24.16
The Read: 2%, with past catalysts like strong Phase 3 trial initiations and positive ASCO data driving up to 8.
No Data